Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-09 |
mRNA | SEPT5 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | CASP2 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
mRNA | TMEM74 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |